|
業務類別
|
Biotechnology |
|
業務概覽
|
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors. |
| 公司地址
| 18 Campus Boulevard, Suite 100, Newtown Square, PA, USA, 19073 |
| 電話號碼
| +1 628 277-4836 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.arrivent.com |
| 員工數量
| 77 |
| Mr. Winston Kung, M.B.A. |
Chief Financial Officer, Principal Accounting Officer and Treasurer |
美元 469.60K |
28/04/2025 |
| Dr. Zhengbin Yao, PhD |
Chairman of Board and Chief Executive Officer |
美元 558.18K |
28/04/2025 |
| Dr. Stuart Lutzker, M.D.,PhD |
Director and President, Research and Development |
美元 495.94K |
28/04/2025 |
| Mr. James Paul Kastenmayer, J.D.,PhD |
General Counsel and Secretary |
-- |
28/04/2025 |
| Ms. Robin LaChapelle, M.D. |
Chief Operating Officer |
-- |
28/04/2025 |
|
|
| Dr. John A. Hohneker, M.D. |
Independent Director |
28/04/2025 |
| Dr. Carl L. Gordon, C.F.A.,PhD |
Director |
28/04/2025 |
| Mr. Christian W. Nolet, C.P.A. |
Independent Director |
28/04/2025 |
| Dr. Zhengbin Yao, PhD |
Chairman of Board and Chief Executive Officer |
28/04/2025 |
| Dr. Stuart Lutzker, M.D.,PhD |
Director and President, Research and Development |
28/04/2025 |
| Dr. Merdad V. Parsey, M.D.,PhD |
Independent Director |
28/04/2025 |
| Ms. Kristine Peterson |
Lead Independent Director |
28/04/2025 |
| Dr. James I. Healy, M.D.,PhD |
Independent Director |
28/04/2025 |
|
|
|
|
